Cited by 175Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesCardiac Imaging and Diagnostics

Current Management of Calcific Aortic Stenosis

Open access
Lindman, Brian R., Bonow, Robert O., Otto, Catherine M.·2013·Circulation Research

Abstract

Calcific aortic stenosis is a progressive disease with no effective medical therapy that ultimately requires aortic valve replacement (AVR) for severe valve obstruction. Echocardiography is the primary diagnostic approach to define valve anatomy, measure aortic stenosis severity, and evaluate the left ventricular response to chronic pressure overload. In asymptomatic patients, markers of disease progression include the degree of leaflet calcification, hemodynamic severity of stenosis, adverse left ventricular remodeling, reduced left ventricular longitudinal strain, myocardial fibrosis, and pulmonary hypertension. The onset of symptoms portends a predictably high mortality rate unless AVR is performed. In symptomatic patients, AVR improves symptoms, improves survival, and, in patients with left ventricular dysfunction, improves systolic function. Poor outcomes after AVR are associated with low-flow low-gradient aortic stenosis, severe ventricular fibrosis, oxygen-dependent lung disease, frailty, advanced renal dysfunction, and a high comorbidity score. However, in most patients with severe symptoms, AVR is lifesaving. Bioprosthetic valves are recommended for patients aged >65 years. Transcatheter AVR is now available for patients with severe comorbidities, is recommended in patients who are deemed inoperable, and is a reasonable alternative to surgical AVR in high-risk patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.111.300084

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Severe aortic stenosis primarily impairs quality of life by causing heart failure symptoms including shortness of breath, fatigue and diminished functional capacity.

    “Severe AS primarily impairs quality of life by causing heart failure symptoms including shortness of breath, fatigue and diminished functional capacity199;252.”

    From Calcific aortic stenosis (2016) · cites this paper as [199]

    The 'Symptom onset' section identifies exertional dyspnea as the most common early symptom and describes declining exercise tolerance and functional capacity in adults with severe AS. The 'Heart failure' section also discusses heart failure symptoms in severe AS. Our copy does not identify fatigue or establish that these symptoms are the primary way severe AS impairs quality of life. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • No pharmacotherapy specifically targets aortic stenosis to prevent progressive leaflet calcification or delay valve replacement.

    “there is no pharmacotherapy specifically targeting AS to prevent progressive leaflet calcification or to delay time to valve replacement3;199.”

    From Calcific aortic stenosis (2016) · cites this paper as [199]

  • Aortic valve replacement is indicated in patients with severe symptomatic aortic stenosis both to increase life expectancy and to improve symptoms and quality of life.

    “AVR is indicated in patients with severe symptomatic AS both to increase life expectancy and improve symptoms and quality of life3;4;199;202;252;253.”

    From Calcific aortic stenosis (2016) · cites this paper as [199]

    Experimental — accuracy not yet measured
  • This LV response considerably influences the morbidity and mortality of aortic stenosis.

    “In many ways, this LV response considerably influences the morbidity and mortality of the disease199;257–260.”

    From Calcific aortic stenosis (2016) · cites this paper as [199]

  • The LV response to chronic pressure overload from aortic stenosis is characterized by hypertrophic remodelling with myocyte hypertrophy and fibrosis, and by diastolic and systolic dysfunction.

    “The LV response to chronic pressure overload from AS is characterized by hypertrophic remodelling (myocyte hypertrophy and fibrosis) and diastolic and systolic dysfunction.”

    From Calcific aortic stenosis (2016) · cites this paper as [199]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lindman, B. R., Bonow, R. O., & Otto, C. M.
Affiliations
Northwestern University (US)
Venue
Circulation Research
Published
2013-07-05
Volume
113
Issue
2
Pages
223-237
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2135349455
Cited by
175
References
118
Citations by year
2026: 8 · 2025: 7 · 2024: 9 · 2023: 5 · 2022: 12 · 2021: 15 · 2020: 23 · 2019: 9 · 2018: 7 · 2017: 19 · 2016: 19 · 2015: 18 · 2014: 20 · 2013: 4
FWCI
3.47
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (KL2TR000450, UL1TR000448)
  • National Heart, Lung, and Blood Institute (L30 HL104696, K23HL116660)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Keywords
calcific aortic stenosis, aortic valve replacement, transcatheter aortic valve implantation, bioprosthetic heart valves, left ventricular remodeling, low-flow low-gradient aortic stenosis, myocardial fibrosis, pulmonary hypertension, frailty, comorbidities, disease progression biomarkers, left ventricular longitudinal strain
MeSH terms
Animals, Aortic Valve Stenosis, Calcinosis, Humans, Cardiomyopathies, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review